AnPac Bio-Medical Science Co., Ltd. (ANPC) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate AnPac Bio-Medical Science Co., Ltd.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.60
Burn Risk
P/B Ratio
-4.51
Equity Deficit
Earnings Yield
-1.68%
Yield Gap
Profitability Health
2022Return on Equity
757.52%
Strong
WeakModerateStrong
Operating Margin
-698.59%
Weak
WeakModerateStrong
Net Profit Margin
-860.16%
Weak
WeakModerateStrong
Growth Indicators
2022Revenue Growth
-33.04%
Weak
WeakModerateStrong
Net Income Growth
13.73%
Moderate
WeakModerateStrong
EPS Growth
69.31%
Strong
WeakModerateStrong
Efficiency & Liquidity
2022Current Ratio
0.32
Weak
WeakModerateStrong
Quick Ratio
0.32
Weak
WeakModerateStrong
Asset Turnover
0.30x
Weak
WeakModerateStrong
Inventory Turnover
17.66x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-91.79%
Weak
WeakModerateStrong
EV / Free Cash Flow
-1.27x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.10x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.257
Strong
WeakModerateStrong
Return on Invested Capital
-20.66%
Weak
WeakModerateStrong
Cash Conversion Cycle
-18.91 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ANPC.
View Financial Statements